2007
Visbal, 2001, Ivor Lewis esophagogastrectomy for esophageal cancer, Ann Thorac Surg, 71, 1803, 10.1016/S0003-4975(01)02601-7
Jaroszewski, 2004, Cancer of the esophagus, 57
Chak, 2004, Neoadjuvant therapy for esophageal cancer, 356
Behzadi, 2005, Esophagogastrectomy: the influence of stapled versus hand-sewn anastomosis on outcome, J Gastrointest Surg, 9, 1031, 10.1016/j.gassur.2005.06.025
Vigneswaran, 1994, Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus, J Thorac Cardiovas Surg, 107, 901, 10.1016/S0022-5223(94)70348-5
Vigneswaran, 1993, Transhiatal esophagectomy for carcinoma of the esophagus, Ann Thorac Surg, 56, 838, 10.1016/0003-4975(93)90341-E
2002
Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452
Cox, 1972, Regression models and life tables (with discussion), J Royal Stat Soc Series B, 34, 187
Peto, 1972, Asymptotically efficient rank invariant procedures (with discussion), J Royal Stat Soc Series A, 135, 185, 10.2307/2344317
Donington, 2003, Tumor response to induction chemoradiation: influence on survival after esophagectomy, Eur J Cardiothorac Surg, 24, 631, 10.1016/S1010-7940(03)00397-X
Donington, 2004, Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus, Ann Thorac Surg, 77, 1193, 10.1016/j.athoracsur.2003.09.029
Jatoi, 2007, Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer, Am J Clin Oncol, 30, 507, 10.1097/COC.0b013e31805c139a
Miller, 2006, Intraoperative radiotherapy for treatment of locally advanced and recurrent esophageal and gastric adenocarcinomas, Dis Esophagus, 19, 487, 10.1111/j.1442-2050.2006.00626.x
Walsh, 1996, A comparison of multimodal therapy and surgery for esophageal adenocarcinoma, N Engl J Med, 335, 462, 10.1056/NEJM199608153350702
Urba, 2001, Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma, J Clin Oncol, 19, 305, 10.1200/JCO.2001.19.2.305
Le Prise, 1994, A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus, Cancer, 73, 1779, 10.1002/1097-0142(19940401)73:7<1779::AID-CNCR2820730702>3.0.CO;2-T
Franklin, 1983, Combined modality therapy for esophageal squamous cell carcinoma, Cancer, 51, 1062, 10.1002/1097-0142(19830315)51:6<1062::AID-CNCR2820510615>3.0.CO;2-2
Leichman, 1984, Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach, J Clin Oncol, 2, 75, 10.1200/JCO.1984.2.2.75
Seydel, 1988, Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG study, Int J Radiat Oncol Biol Phys, 14, 33, 10.1016/0360-3016(88)90047-8
Poplin, 1987, Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Study Group (SWOG-8037), J Clin Oncol, 5, 622, 10.1200/JCO.1987.5.4.622
Forastiere, 1993, Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report, J Clin Oncol, 11, 1118, 10.1200/JCO.1993.11.6.1118
Adelstein, 1997, Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma, Cancer, 80, 1011, 10.1002/(SICI)1097-0142(19970915)80:6<1011::AID-CNCR2>3.0.CO;2-C
Kesler, 2005, A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone, Ann Thorac Surg, 79, 1116, 10.1016/j.athoracsur.2004.08.042
Rohatgi, 2005, Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response, Cancer, 104, 2365, 10.1002/cncr.21439
Schneider, 2005, Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiotherapy for esophageal cancer, Ann Surg, 242, 684, 10.1097/01.sla.0000186170.38348.7b
Hammoud, 2006, Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer, Dis Esophagus, 19, 69, 10.1111/j.1442-2050.2006.00542.x
Rizk, 2007, American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma, J Clin Oncol, 25, 507, 10.1200/JCO.2006.08.0101
Swisher, 2005, Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT), Ann Surg, 241, 810, 10.1097/01.sla.0000161983.82345.85
Rohatgi, 2005, Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus, Cancer, 104, 1349, 10.1002/cncr.21346
Rizk, 2006, The prognostic importance of the number of involved lymph nodes in esophageal cancer; implications for revisions of the American Joint Committee on Cancer Staging System, J Thorac Cardiovasc Surg, 132, 1374, 10.1016/j.jtcvs.2006.07.039
Hofstetter, 2007, Proposed modification of nodal status in AJCC esophageal cancer staging system, Ann Thorac Surg, 84, 365, 10.1016/j.athoracsur.2007.01.067
Berger, 2005, Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival, J Clin Oncol, 23, 4330, 10.1200/JCO.2005.05.017
Lin, 2004, Induction therapy does not increase surgical morbidity after esophagectomy for cancer, Ann Thorac Surg, 78, 1783, 10.1016/j.athoracsur.2004.04.081
Agarwal, 2005, Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux, Ann Thorac Surg, 79, 1716, 10.1016/j.athoracsur.2004.10.026
Rohatgi, 2006, Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome, Dis Esophagus, 19, 152, 10.1111/j.1442-2050.2006.00557.x
Rohatgi, 2006, Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy, Cancer, 106, 552, 10.1002/cncr.21601